Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03343197
Title Study of AG-120 and AG-881 in Subjects With Low Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Agios Pharmaceuticals, Inc.
Indications

malignant astrocytoma

oligodendroglioma

Therapies

Ivosidenib

AG-881

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST